Martinowitz U - Search Results

1

Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors.

Kenet G, Martinowitz U. Kenet G, et al. Among authors: martinowitz u. Semin Hematol. 2008 Apr;45(2 Suppl 1):S38-41. doi: 10.1053/j.seminhematol.2008.03.011. Semin Hematol. 2008. PMID: 18544424 Review.

2

Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E. Martinowitz U, et al. Can J Anaesth. 2002 Dec;49(10):S15-20. Can J Anaesth. 2002. PMID: 12546003

3

A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor.

Livnat T, Martinowitz U, Zivelin A, Rima D, Kenet G. Livnat T, et al. Among authors: martinowitz u. Thromb Haemost. 2011 Apr;105(4):688-95. doi: 10.1160/TH10-08-0542. Epub 2011 Jan 12. Thromb Haemost. 2011. PMID: 21225093

4

The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency.

Misgav M, Lubetszki A, Brutman-Barazani T, Martinowitz U, Kenet G. Misgav M, et al. Among authors: martinowitz u. J Vasc Access. 2017 May 15;18(3):220-224. doi: 10.5301/jva.5000707. Epub 2017 Apr 28. J Vasc Access. 2017. PMID: 28478622

5

Surfactant impairs coagulation in-vitro: a risk factor for pulmonary hemorrhage?

Strauss T, Rozenzweig N, Rosenberg N, Shenkman B, Livnat T, Morag I, Fruchtman Y, Martinowitz U, Kenet G. Strauss T, et al. Among authors: martinowitz u. Thromb Res. 2013 Nov;132(5):599-603. doi: 10.1016/j.thromres.2013.09.001. Epub 2013 Sep 6. Thromb Res. 2013. PMID: 24071465

6

Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B.

Martinowitz U, Lubetsky A. Martinowitz U, et al. Thromb Res. 2013 Mar;131 Suppl 2:S11-4. doi: 10.1016/S0049-3848(13)70152-X. Thromb Res. 2013. PMID: 23537721 Clinical Trial.

7

Treating traumatic bleeding in a combat setting: possible role of recombinant activated factor VII.

Martinowitz U, Zaarur M, Yaron BL, Blumenfeld A, Martonovits G. Martinowitz U, et al. Mil Med. 2004 Dec;169(12 Suppl):16-8, 4. doi: 10.7205/milmed.169.12s.16. Mil Med. 2004. PMID: 15651435 Review.

8

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

Santagostino E, Martinowitz U, Lissitchkov T, Pan-Petesch B, Hanabusa H, Oldenburg J, Boggio L, Negrier C, Pabinger I, von Depka Prondzinski M, Altisent C, Castaman G, Yamamoto K, Álvarez-Roman MT, Voigt C, Blackman N, Jacobs I; PROLONG-9FP Investigators Study Group. Santagostino E, et al. Among authors: martinowitz u. Blood. 2016 Apr 7;127(14):1761-9. doi: 10.1182/blood-2015-09-669234. Epub 2016 Jan 11. Blood. 2016. PMID: 26755710 Free PMC article. Clinical Trial.

9

Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).

Segal S, Shemesh IY, Blumenthal R, Yoffe B, Laufer N, Ezra Y, Levy I, Mazor M, Martinowitz U. Segal S, et al. Among authors: martinowitz u. Arch Gynecol Obstet. 2003 Oct;268(4):266-7. doi: 10.1007/s00404-002-0409-1. Epub 2002 Nov 7. Arch Gynecol Obstet. 2003. PMID: 14504866

10

Continuous infusion of coagulation factors: current opinion.

Batorova A, Martinowitz U. Batorova A, et al. Among authors: martinowitz u. Curr Opin Hematol. 2006 Sep;13(5):308-15. doi: 10.1097/01.moh.0000239701.32674.e0. Curr Opin Hematol. 2006. PMID: 16888434 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page